184 related articles for article (PubMed ID: 37998338)
61. IQGAP1 enhances cell invasion and matrix metalloproteinase-2 expression through upregulating NF-κB activity in esophageal squamous cell carcinoma cells.
Zhang Z; Wei Y; Li X; Zhao R; Wang X; Yang Z; Li T; Wang X; Li X; Wang X
Gene; 2022 May; 824():146406. PubMed ID: 35276237
[TBL] [Abstract][Full Text] [Related]
62. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
63. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
Du F; Guo T; Cao C
Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
[TBL] [Abstract][Full Text] [Related]
64. SPI1-Mediated Upregulation of the
Luo FF; Wang J; Zhang ZF; Lin ST; Huang TJ; Liu BQ; Fan ML; Peng LX; Zheng ST; Yang CF; Huang BJ
Front Biosci (Landmark Ed); 2023 Sep; 28(9):212. PubMed ID: 37796690
[TBL] [Abstract][Full Text] [Related]
65. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
[TBL] [Abstract][Full Text] [Related]
66. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
67. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
68. Reticulocalbin3: A Ca
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Hong C; Lin J
Cancer Sci; 2022 Oct; 113(10):3593-3607. PubMed ID: 35839283
[TBL] [Abstract][Full Text] [Related]
69. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
70. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
Li FZ; Zang WQ
World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
[TBL] [Abstract][Full Text] [Related]
71. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
[TBL] [Abstract][Full Text] [Related]
72. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
[TBL] [Abstract][Full Text] [Related]
73. miR-25 promotes metastasis via targeting FBXW7 in esophageal squamous cell carcinoma.
Hua Y; Zhao K; Tao G; Dai C; Su Y
Oncol Rep; 2017 Nov; 38(5):3030-3038. PubMed ID: 29048664
[TBL] [Abstract][Full Text] [Related]
74. LAMC1 upregulation via TGFβ induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-κB-CXCL1-STAT3.
Fang L; Che Y; Zhang C; Huang J; Lei Y; Lu Z; Sun N; He J
Mol Oncol; 2021 Nov; 15(11):3125-3146. PubMed ID: 34218518
[TBL] [Abstract][Full Text] [Related]
75. MAFB promotes the malignant phenotypes by IGFBP6 in esophageal squamous cell carcinomas.
Zhang S; Gong T; Nan Y; Feng R; Liu Z; Chen H
Exp Cell Res; 2022 Jul; 416(1):113158. PubMed ID: 35430273
[TBL] [Abstract][Full Text] [Related]
76. LINC01004-SPI1 axis-activated SIGLEC9 in tumor-associated macrophages induces radioresistance and the formation of immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma.
Zhao F; Tian H; Wang Y; Zhang J; Liu F; Fu L
Cancer Immunol Immunother; 2023 Jun; 72(6):1835-1851. PubMed ID: 36688997
[TBL] [Abstract][Full Text] [Related]
77. Upregulation of PAX2 promotes the metastasis of esophageal cancer through interleukin-5.
Liu P; Gao Y; Huan J; Ge X; Tang Y; Shen W; Tian Y; Shen W; Zou S; Zhou J; Zhang S
Cell Physiol Biochem; 2015; 35(2):740-54. PubMed ID: 25613757
[TBL] [Abstract][Full Text] [Related]
78. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
[TBL] [Abstract][Full Text] [Related]
79. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
80. A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.
Sun G; Hu W; Lu Y; Wang Y
Pathol Oncol Res; 2013 Oct; 19(4):685-93. PubMed ID: 23658132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]